New Zealand markets closed

FusionPharm, Inc. (FSPM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -24.73
52-week change 30.00%
S&P500 52-week change 321.08%
52-week high 30.0151
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 510.59M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 327 Feb 1998
Ex-dividend date 4N/A
Last split factor 21:200
Last split date 301 Mar 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2011
Most-recent quarter (mrq)31 Mar 2012

Profitability

Profit margin -110.72%
Operating margin (ttm)-124.14%

Management effectiveness

Return on assets (ttm)-137.69%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)328.69k
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-363.93k
Diluted EPS (ttm)-0.1470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.45k
Total cash per share (mrq)0
Total debt (mrq)295.7k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.73
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-286.51k
Levered free cash flow (ttm)-254.22k